Incidence and Characterisation of Persistent Pain in COVID-19 Survivors: A pan-European Concerted Action
- Funded by Novo Nordisk Foundation
- Total publications:0 publications
Grant number: N/A
Grant search
Key facts
Disease
COVID-19Start & end year
N/AKnown Financial Commitments (USD)
$1,279,584.1Funder
Novo Nordisk FoundationPrincipal Investigator
Professor Lars Arendt-NielsenResearch Location
N/ALead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Clinical characterisation and managementResearch Subcategory
Disease pathogenesisSpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified